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Abstract
Background . Surgical resection is the best established treatment known to provide long-term survival and possibility of cure
for liver malignancy. Intraoperative blood loss has been the major concern during major liver resections, and mortality and
morbidity of surgery are clearly associated with the amount of blood loss. Different techniques have been developed to
minimize intraoperative blood loss during liver resection. The radiofrequency ablation (RFA) technique has been used
widely in the treatment of unresectable liver tumors. This review concentrates on the use of RFA to provide an avascular
liver resection plane. Methods and results . The following review is based on two types of RFA device during liver resection:
single needle probe RFA and the In-Line RFA device. Conclusion . Liver resection assisted by RFA is safe and is associated
with very limited blood loss.
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Introduction
Both primary and metastatic cancers of the liver are
common and lethal diseases. In Western countries,
primary liver cancer is comparatively rare, but is
rapidly increasing due to the increased prevalence of
hepatitis C, and metastatic colorectal carcinoma is the
major indication for liver resection [13]. Primary
liver cancer is, however, much more common in other
parts of the world, representing 1050% of malig-
nancies in Africa and parts of Asia [46].
Currently, surgical resection is the optimal treat-
ment known to provide long-term survival and
possibility of cure for both primary and metastatic
liver cancer [79]. Unfortunately, intraoperative
blood loss has been a major concern during major
liver resections, and mortality and morbidity are
clearly associated with the amount of blood loss
[10,11]. The mean blood loss has been reported to
be between 600 ml and 1300 ml [12,13], with 28
47% of the patients requiring blood transfusion
[12,14]. Several studies have shown that blood loss
correlates adversely with length of hospital stay,
complication rate, and patient survival [15,16]. It
also has been shown that patients requiring more than
10 units of blood after liver resection for colorectal
cancer metastasis have an increased risk of tumor
recurrence and poor survival, probably due to im-
munosuppression [17,18].
Therefore, over the past decade many techniques
have been developed to minimize intraoperative blood
loss during liver resection [1922]. Surgeons can
decrease intraoperative blood loss by using hypoten-
sive anesthesia to reduce the central venous pressure
[23], Pringle’s maneuver [24], or total vascular
exclusion [25]. Parenchymal transection can be per-
formed with the finger fracture or Kelly clamp/crush,
using the ultrasonic dissector [20], the WaterJet
dissector [26], or stapling devices [27].
Radiofrequency ablation (RFA) has been broadly
used for unsectable liver tumors and produces coa-
gulative necrosis of the liver parenchyma and throm-
bosis and coagulation of small blood vessels [2833].
Several recent studies have shown that the use of RFA
to assist liver resection decreased blood loss dramati-
cally [3444]. This new technique employs the heat
produced by the radiofrequency device to coagulate
the liver tissue before resecting it. A plane of tissue is
coagulated by the RFA device, after which resection is
performed along the coagulated tissue plane. By using
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Table I. Clinical details of RFA-assisted liver resection.
First author Medical center, city, country Year No.
Age
(years) Types of resection
Operation time
(min) Blood loss Transfusion Complication
Hospital stay
(days)
Navarra [34] Department of Human Pathology,
University of Messina, Messina, Italy
01/2001
01/2002
27 Open hepatectomy 47.5 (30110) 30 ml (15992) Nil Nil 8 (586)
Tepel [36] Klinik fur Allgemeine Chirurgie und
Thoraxchirurgie, Universitatsklinikum
Schleswig-Holstein, Campus Kiel,
Germany
7 74 (4178) 1 segment (2); 2
segments (3);/2
segment (2)
1 case Second degree
burn to the
thigh (1); bile
leak (1)
Navarra [37] Department of Surgical Oncology and
Technology, Imperial College School
of Medicine, Hammersmith Hospital
Campus, London, UK
01/2001
07/2002
42 57.5 (2579) 1 segment (13); 2
segments (16);/2
segment (13)
50 (30110) 30 ml (15992) Nil Subphrenic
abscess (1);
chest infection
(1);
biliary leak (1)
Weber [38] Department of Surgical Oncology and
Technology, Faculty of Medicine,
Imperial College of Science, Technology
and Medicine, Hammersmith Hospital
Campus, London, UK
01/2000
06/2001
15 59 (3675) 1 segment (8); 2
segments (6);/2
segments (1)
205 (95300) 309/10 ml Nil Nil 8 (59)
Beppu [39] Department of Gastroenterological
Surgery, Graduate School of Medical
Sciences, Kumamoto University,
Kumamoto, Japan
2004 7 64 Laparoscopic
hepatectomy
256 96 g Nil Nil 11
Weber [40] Centre de Chirurgie Viscerale et
Transplantation, Hopitaux
Universitaires de Strasbourg,
Avenue Moliere, Strasbourg, France
2002 1 43 Laparoscopic
hepatectomy
300 75 ml Nil Nil 6
Stella [42] Department of Surgery, Santa Corona
Hospital, Pietra Ligure, Savona, Italy
06/2002
11/2002
8 64.8 (5572) 1 segment (3); 2
segments (3);/2
segments (2)
220 (170420) 46 ml (5150) Nil Abscess (1) 9.4 (520)
Navarra [43] Department of Surgical Oncology and
Technology, Faculty of Medicine,
Imperial College of Science, Technology
and Medicine, Hammersmith Hospital
Campus, London, UK
2002 1 Right
hepatectomy
80 30 ml Nil Nil 9
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this technique, blood loss has significantly decreased
to a mean of 30 ml [38].
Currently, there are two types of RFA device used
in liver resection: single needle probe RFA and In-
Line RFA. Both were successfully used in animal and
patient experiments to reduce blood loss in liver
surgery. This review will attempt to characterize the
unique clinical features of RFA-assisted liver resec-
tion.
Methods
Single needle probe RFA
RFA-assisted liver resections using a single needle
probe have been done in different medical centres
(Table I). All patients underwent careful preoperative
assessment for their disease, including spiral com-
puted tomography (CT) scanning or magnetic reso-
nance imaging (MRI), and showed no evidence of
unresectable extrahepatic disease. Surgical resections
ranged from multiple metastasectomies to bisegmen-
tectomies.
Liver resections were carried out under general
anesthesia. The peritoneal cavity was examined for
evidence of extrahepatic disease. After dividing intra-
abdominal adhesions and the falciform ligament, the
liver was then mobilized according to the size and site
of the lesion to be resected. An intraoperative ultra-
sonogram was always performed prior to liver resec-
tion.
Habib’s group has previously described the techni-
que of RFA-assisted liver resection [38]. In step 1
(Figure 1), an inner line is made on the liver surface
with diathermy to mark the periphery of the tumor,
assisted with bimanual palpation and intraoperative
ultrasound. It is important to do this first, because
after RFA is used, the parenchyma is hardened and it
becomes difficult to feel the tumor edge. Also, after
RFA, it is impossible to visualize the tumor edge with
intraoperative ultrasound; this is a real and important
difference which must be understood with all RFA-
assisted liver resections.
In step 2, an outer line, again using diathermy, is
made on the liver capsule 2 cm outside (away from)
the inner line to mark the site where the probe is going
to achieve coagulative necrosis.
In step 3, coagulative necrosis is produced along the
outer line using a RFA probe, whilst Habib’s group
have used the saline-cooled RFA probe; essentially all
ablation devices can be used for this purpose.
In step 4, further probe applications are deployed to
obtain a zone of necrosis according to the depth of the
liver parenchyma to be resected. Each application of
RFA energy will need to be applied for about 60 s.
The surgeon should check that each probe is correctly
positioned by means of ultrasound.
In step 5, the liver parenchyma is transected by
using the scalpel. The plane of division should be
situated midway between the inner and outer line so
as to leave a 1 cm resection margin away from the
tumor and leave in situ 1 cm of burned coagulated
surface.
All of these groups achieved very good results
[34,3640,42,43] (Table I). Habib et al. demon-
strated that blood loss could be reduced to B/309/
10 ml for a right hepatectomy, and practically zero
blood loss on most occasions [38]. In all of their 108
patients, only one case needed blood transfusion [36].
Other complications included: one second degree
burn to the thigh [36], two bile leaks [36,37], one
subphrenic abscess [37], and one chest infection [37].
These complications were from two studies [36,37].
Patients in other studies underwent an uneventful
recovery; no significant bile leak, abscess, or require-
ment for transfusion was encountered.
In-Line RFA
The In-Line RFA device was developed by our group
[35,41]. The principle of the In-Line RFA device is
that a very precise RFA area is created between
electrodes of alternating polarity leading to localized
heating and coagulation of tissue including blood
vessels up to approximately 3 mm. This transection
plane is then dissected almost bloodlessly and the
larger vessels/biliary structures are tied, sewn or
otherwise secured.
The In-Line radiofrequency ablation probe (Figure
2) is a 5 cm long plastic device and it comprises six
metal electrodes spaced along the device, each 6 cm
long. The electrodes can be deployed to any depth up
to a maximum of 4 or 6 cm depending on the model
used (Figures 3 and 4). The effective length of the
coagulation is 5 cm and its width is 1 cm (Figure 5).
The In-Line RFA device is bipolar and does not
require a patient return plate.
Before use, the resection line should be marked. In
nonanatomic resection, we transect the liver along this
line; in anatomic resection, after dividing the land-
mark vessels on the cutting surface, we deploy the In-
Line RFA along this resection line. We strongly
Figure 1. Single needle probe RFA-assisted liver resection. T,
tumor; IL, inner line; OL, outer line; RP, resection plane.
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recommend that intraoperative ultrasound is used to
ensure that there are no important structures in the
chosen resection line. This is particularly important
when a vascular biliary sheath crosses the resection
plane and must be avoided. The In-Line RFA device
will coagulate almost any structure that it encounters
and this should not be deployed through or within
1 cm of a structure that must not be damaged.
During coagulation, the device will become very
hot and the operator should hold the handle rather
than the body of the device. A start out coagulation
time of 3 min is used, after which the electrodes are
twisted half a turn and pulled back individually. The
probe is removed. The electrodes should be rede-
ployed and cleaned if further coagulation is required.
The device is re-used until the resection line has been
completely treated  typically three applications are
required for a right hepatectomy.
The parenchymal dissection of the coagulated
transaction line is now completed using either the
Kelly crush or a more sophisticated means of transec-
tion, such as the ultrasonic dissector or WaterJet.
Large vessels and sheaths which are revealed by this
dissection may then be ligated, sewn, clipped, or
otherwise secured.
In our earlier experiments, we demonstrated that
In-Line RFA-assisted liver resection could reduce
blood loss dramatically [35,41]. In a pilot study of
eight patients where half of each resection was done
with In-Line RFA and the remainder with an ultra-
sonic aspirator alone, we also reported a significant
difference in blood loss (p/0.004) [44]. From March
2002 to November 2004, a total of 38 patients
underwent In-Line RFA-assisted liver resection, 12
were anatomic resections, the majority of the remain-
ing resections were bisegmentectomy (Table II). The
mean blood loss was 509/12.64 ml, and all of
38 patients had an uneventful recovery. During the
postoperative period, no significant increase in bile
leaks, abscess, or secondary hemorrhage was found
[45]; however, we accept that this is undoubtedly an
issue that requires further monitoring.
Conclusion
RFA has been used to treat liver tumors for many
years. In 1990 McGahan et al. and Rossi et al. used
RFA to destroy hepatic tumors in animal livers
[46,47]. Since then, RFA has been used widely in
the treatment of unresectable liver tumors [4851].
Figure 4. Prototype In-Line RFA deployment.
Figure 5. Avascular liver resection plane.
Figure 2. Prototype In-Line RFA probe.
Figure 3. Prototype In-Line RFA deployment.
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Furthermore, RFA of liver tumors is currently being
performed percutaneously and laparoscopically [52
55].
The first description of RFA-assisted liver resection
was published by Habib’s group [38]. This technique
was clearly a major advance, and no morbidity and
mortality were observed. It was shown that anesthetic
time, operative time, hospital stay, and amount of
blood loss could be decreased. Liver resection became
a comparatively safer procedure. Subsequent studies
demonstrated the merit of this technique
[34,36,37,39,40,42,43].
Our In-Line RFA device is bipolar which has many
advantages [56,57]. The monopolar system is very
slow approach, requiring many ablations to cover the
designed resection plane. On the contrary, our In-
Line device allows much more rapid (3 min for 6/
5/1 cm) and precise treatment. The resection plane
then can be dissected almost bloodlessly with an
ultrasonic aspirator and only a few larger vessels and
biliary ducts need to be ligated. Secondly, the bipolar
device does not require grounding pads, because
both electrodes are located on the probe and the
alternating current circuit is confined within the target
tissue.
Before use, the resection line should be marked. We
recommend that intraoperative ultrasound is used to
ensure that there are no important structures in
the chosen resection line. This is particularly impor-
tant when a vascular biliary sheath crosses the
resection plane and must be avoided. The In-Line
RFA device will coagulate almost any structure that it
encounters and this should not be deployed through
or within 1 cm of a structure that must not be
damaged.
The In-Line device can similarly be used in
segmental liver resection and nonanatomical resec-
tions. It is easy to learn to use the device. We believe
the ability to sculpt a resection will be a useful tool in
parenchymal sparing hepatic surgery, particularly in
cirrhotics. The technique of RFA-assisted liver resec-
tion has a promising future.
Table II. Clinical details of In-Line RFA-assisted liver resection.
No. Sex Date of treatment Resection segments Blood loss (ml) Liver quality
1 F 3/12/2002 Left hepatectomy 60 Normal
2 M 8/24/2002 Right hepatectomy 80 Mild steatosis
3 M 8/31/2002 S 6,7 50 Normal
4 M 8/1/2003 S 6,7 50 Severe steatosis
5 M 8/2/2003 S 6 50 Normal
6 F 8/2/2003 S 6,7 0 Normal
7 F 8/6/2003 S 5,6 50 Normal
8 F 8/23/2003 S 3 20 Normal
9 M 10/9/2003 S 8 0 Normal
10 M 10/12/2003 S 6,7 50 Cirrhotic
11 F 10/12/2003 Right hepatectomy 80 Normal
12 F 10/17/2003 S 2,3 0 Normal
13 F 10/17/2003 S 4a 0 Normal
14 F 12/4/2003 S 7,8 60 Mild steatosis
15 M 12/6/2003 S 4,5,8 70 Mild steatosis
16 F 12/10/2003 S 5,6 40 Moderate steatosis
17 M 12/11/2003 S 4b 0 Mild steatosis
18 M 12/12/2003 S 4 0 Mild steatosis
19 F 12/20/2003 Right hepatectomy 90 Normal
20 F 12/21/2003 S 5,6,7 50 Moderate steatosis
21 M 5/11/2004 S 4b, 5,6 50 Normal
22 F 5/12/2004 S 6 0 Cirrhotic
23 F 5/15/2004 Extended left hepatectomy 100 Mild steatosis
24 M 5/15/2004 S 2,3 0 Mild steatosis
25 M 6/19/2004 Left hepatectomy 80 Normal
26 M 6/25/2004 S 5,6,7 60 Normal
27 F 6/26/2004 S 7-subs 40 Normal
28 F 7/9/2004 Right hepatectomy 100 Mild steatosis
29 M 7/24/2004 Left hepatectomy 80 Cirrhotic
30 M 7/28/2004 Right hepatectomy 100 Mild steatosis
31 M 8/31/2004 Right hepatectomy 90 Mild steatosis
32 M 9/10/2004 S 6,7 60 Normal
33 F 10/6/2004 S 2, 3 0 Mild steatosis
34 M 10/7/2004 S 2,3 0 Normal
35 M 10/14/2004 S 7,6 50 Mild steatosis
36 M 10/21/2004 Extended left hepatectomy 150 Mild steatosis
37 F 11/2/2004 Right hepatectomy 100 Normal
38 F 11/7/2004 S 2,3 40 Normal
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